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We congratulate Gomez et al1 for their very important contribution 
on the patterns of failure, toxicity, and 
survival after extrapleural pneumonec-
tomy and hemithoracic intensity-mod-
ulated radiation therapy, for malignant 
pleural mesothelioma. Studies about 
patterns of failure are of great impor-
tance because patterns of local and dis-
tant failure might be the most important 
test of adequate treatment planning and 
treatment success.2
After extrapleural pneumonec-
tomy and hemithoracic intensity-mod-
ulated radiation therapy, only 16% of 
the patients experienced local recur-
rence, whereas, distant recurrence was 
observed in 59% of the patients. If we 
go into details, the predominant site 
of distant recurrence was contralat-
eral hemithorax in the majority of the 
patients (41%; n = 35) followed by 
abdomen and pelvis, including liver in 
28% of the patients (n = 24).
In general, distant recurrence 
is defined as tumor that has spread to 
organs or tissues distant from the pri-
mary tumor. However, contralateral 
hemithorax and abdomen are located 
directly at the resection borders. 
Contralateral pleura and peritoneum 
could be opened accidentally during 
extrapleural dissection in the anterior or 
posterior mediastinum and diaphragmal 
resection. Tumor cell dislocation might 
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occur at these resection borders. The 
resection borders are not far away from 
the primary tumor site. It is question-
able whether these kind of recurrences 
might be hematogenous spread. Thus, 
the question arises whether recurrence 
at the resection borders in terms of con-
tralateral hemithorax or abdomen and 
pelvis should be (still) considered as 
local recurrence or distant recurrence 
for malignant pleural mesothelioma?
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In Response:
We thank Drs. Bolukbas, Eberlein, 
and Schirren for their letter and their 
inquiry regarding patterns of recurrence 
for malignant pleural mesothelioma at 
the resection borders. We do concur that 
the classification of recurrence in this 
setting requires special consideration, 
because of the unique components of 
an extrapleural pneumonectomy. And 
indeed, it can be difficult to distinguish 
between microscopic residual disease 
that has occurred at the surgical/radia-
tion field margin versus tumor spread 
hematogenously to the contralateral 
hemithorax or abdomen. Unfortunately, 
there is no way to determine with abso-
lute certainty the process underlying 
these recurrences, particularly with 
the additional concern that has been 
previously published of tumor seeding 
through biopsy or surgery.1,2 Therefore, 
much of the categorization for reporting 
purposes relies on clinical judgment.
In the vast majority of cases that 
we have classified as being distant recur-
rences, the tumors have been located at 
sites not in direct continuity with the 
postpneumonectomy space. Most con-
tralateral lung recurrences in this series 
were intraparenchymal tumor nodules, 
not pleural-based recurrences and are 
most probably related to hematogenous 
spread. Similarly, liver recurrences were 
exclusively intraparenchymal. One cer-
tainly could argue (as has been done in 
the past by others) that intra-abdominal 
recurrences are secondary to seeding at 
the time of surgery and should be clas-
sified as “local” recurrences. However, 
a significant number of patients will 
have occult carcinomatosis before sur-
gery, so transdiaphragmatic spread to 
the abdominal cavity (either by direct 
invasion or, more likely by lymphatog-
enous spread) is a common feature of 
this disease even without violation 
of the diaphragm during extrapleural 
pneumonectomy. It is therefore not sur-
prising that abdominal recurrences are 
observed after cytoreductive surgery.
At our institution, we classify 
recurrence of disease that occurs in a 
region that is clearly in the resection 
bed or at the resection margin above 
the diaphragm, or in the mediastinal 
lymph nodes, as local–regional recur-
rence. In contrast, disease that is evi-
dently removed from the ipsilateral 
hemithorax or is below the diaphragm, 
including contralateral lung nodules, 
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